The Effect of Transrectal Ultrasound-guided Prostate Needle Biopsy on Lower Urinary Tract Symptoms
Journal Title: Üroonkoloji Bülteni - Year 2018, Vol 17, Issue 3
Abstract
Objective: To evaluate the effect of transrectal ultrasound-guided prostate biopsy on lower urinary system symptoms. Materials and Methods: The study included 123 patients who underwent ultrasound-guided prostate biopsy between March 2013 and December 2013. Before and at 2, 4, and 8 weeks after the procedure, the patients completed the International Prostate Symptom Score (IPSS) questionnaire. Storage symptoms (questions 2, 4, 7) and voiding/postvoiding symptoms (questions 1, 3, 5, 6) were separately evaluated. The patients with cancer diagnosis were excluded after the week 4. The cancer-free patients were divided into subgroups based on education level and complication status and followed for 8 weeks to assess changes in IPSS and quality of life. Results: IPSS increased significantly at week 2 follow-up of both the cancerous and cancer-free patients (p=0.041 and p<0.01); however, there was no statistically significant difference between the pre-biopsy scores and week 4 scores (p=0.07 and p=0.09). Voiding/postvoiding symptoms also increased significantly at week 2 for both groups (p=0.04 and p<0.01, respectively). IPSS was significantly higher in all subgroups of cancer-free patients at week 2, in correlation with voiding/postvoiding symptoms. In patients with low education level, there was a significant decrease in IPSS at 4 and 8 weeks compared to pre-biopsy (p=0.031 and p=0.035, respectively). IPSS changes were not associated with prostate volume. Quality of life was significantly reduced in the early period (p<0.01). Conclusion: Lower urinary system symptoms are affected negatively in the early post-biopsy period in correlation with the increase of voiding/postvoiding symptoms. The time required for remission is 15-30 days. The procedure may decrease symptoms in patients with low education level due to the placebo effect.
Authors and Affiliations
Volkan Çağlayan, Sedat Öner, Efe Önen, Sinan Avcı, Mustafa Murat Aydos, Murat Demirbaş
Keywords
Related Articles
- EP ID EP382519
- DOI 10.4274/uob.1021
- Views 100
- Downloads 0
Sentinel Lymph Node Biopsy in Lymphadenectomy for Prostate Cancer
Performing the sentinel lymph node (SLN) biopsy during prostate cancer staging aims to provide more accurate nodal staging with low complications than pelvic lymph node dissection. SLN might be found outside the extended...
Transperitoneal Laparoscopic Nephrectomy-Our Initial Experiences
Objective: To evaluate the first experiences of laparoscopic nephrectomy operations performed in our clinics. Materials and Methods: A total of 61 laparoscopic nephrectomy operations were performed in our clinics during...
Effects and Mechanisms of Checkpoint Inhibitors (CTLA-4, PD-1 and PD-L1 Inhibitors) as New Immunotherapeutic Agents for Bladder Cancer
Since intravesical Bacillus Calmette-Guerin (BCG) began to be used for bladder cancer, our understanding of the importance of immune mechanisms in bladder cancer has steadily grown. With developments in immunotherapy in...
Transurethral Resection of the Bladder Tumor Success Rates of Surgeons and Possible Causes of Differences Between Locals and Refugees
Objective: In our study, we examined the success rates of our surgeons and the criteria that define the success, and tried to reveal the possible causes of the differences in the success rates of transurethral resection...
Comparison of Lidocaine and Prilocaine Efficiencies in Periprostatic Nerve Block for Transrectal Prostate Biopsy: A Randomized Prospective Study
Objective: Periprostatic nerve block (PPNB) and intrarectal local anesthesia (IRLA) are two of the most commonly used methods for pain control in the transrectal ultrasonography (TRUS)-guided prostate needle biopsy proce...